
The £8 Boots buy that's a dupe of posh £49 Kerastase – it makes your hair grow thick and my locks are proof it works
TikTok hair expert Sophia, aka Sofia Hair Health, has revealed an £8.49 miracle product from Asos that could be giving posh £49 Kerastase Genesis a run for its money.
3
3
Sofia, a 24-year-old hair researcher from London, isn't just another influencer flogging the latest fad. She's lived it.
At just 21, she started losing her hair, not just a few strands here and there, but actual bald patches that left her confidence in tatters.
'I'd wake up and see more scalp than hair,' she revealed.
'Then I spotted actual bald patches. I felt like I was disappearing.'
Eventually diagnosed with androgenic alopecia, a genetic condition that causes thinning hair, usually in older women, Sofia was told there was no cure, only ongoing treatments that might help slow it down.
But instead of giving up, she threw herself into studying hair biology and researching every treatment under the sun.
Now, three years on, her glossy, thick locks are proof her efforts paid off.
The hair expert has now put fans onto a humble bottle of L'Oréal Elvive Hair Growth Serum with Aminexil, currently available at Asos for just £8.49.
Buy it here
At Boots, this would set you back £17.
She claims this product has "changed the game".
Sophia said: 'It's got the same powerhouse ingredient as the £49 Kerastase Genesis, aminexil, which helps loosen collagen around the hair follicle and boosts growth.'
How do get the perfect summer glow up with Aldi's latest middle aisle beauty buys including a £4.99 serum that'll revitalise dull skin AND smells amazing
Both Elvive and Kerastase are owned by beauty giant L'Oréal, and according to Sofia, they share more than just a parent company.
She points out that the product also has other key ingredients you'd find in Kerastase, like caffeine and niacinamide, which are both great for stimulating growth and improving scalp health.
But here's where it gets really interesting, L'Oréal reportedly disclosed the concentration of aminexil in Elvive's serum as 1.5%.
In contrast, they've kept quiet about the concentration in the pricier Kerastase Genesis.
Sophia warns this is a red flag and that if Elvive is cheaper and tells you exactly what you're getting, then there's no need to fork out on a £49 "just for a fancy bottle".
Since using the key ingredient in this product her hair has gone from 'lifeless and patchy' to 'thicker, stronger and full of volume.
And judging by the hundreds of glowing comments on her videos, not to mention her jaw-dropping before and after pics, her followers are lapping it up.
Sophia said "you're not missing out on results", just on "the expensive packaging.'
It looks like this hair guru has found our new holy grail and it won't cost half your paycheck.
It's important to remember the prices mentioned reflect the rates at the time of writing.
As prices can change over time, we recommend double-checking before placing an order.
Hair re-growth FAQs
Anabel Kingsley, Consultant Trichologist and Brand President at Philip Kingsley spoke exclusively to Fabulous.
How long does it take for hair to grow back?
Hair grows, on average, half an inch a month. You cannot speed this up.
Do rosemary oil and scalp massages work?
Oils do not promote hair growth. In terms of rosemary oil, the current trend stems from one small study carried out on 50 men in 2015. No women were involved, and the study compared the effects of 2 per cent minoxidil to Rosemary oil. 2 per cent minoxidil doesn't do much for
male pattern hair loss anyway, so the results were not very impressive. Oils do serve a purpose in conditioning hair treatments though. They help add shine and smooth the hair cuticle to lock-in moisture and improve combability. Scalp massages alone won't cure hair loss, but it can help relax you, aid in lymphatic drainage, exfoliate and help topicals penetrate.
Are there any products or foods/vitamins you recommend someone using or eating to help with hair regrowth?
To support healthy hair regrowth, if you are experiencing hair thinning we'd recommend our Density Preserving Scalp Drops clinically proven to help slow hair loss with continued daily use within three months.
Telogen effluvium (hair shedding) due to nutritional deficiencies can often be simply treated with changes to your diet, and nutritional supplements such as our specially formulated Density Healthy Hair Complex and Density Amino Acid Booster.
Iron and Ferritin (stored iron) in red meat, dried apricots and dark, leafy greens. Vitamin B12 in animal products and fortified plant-based foods. Protein from oily fish, lean meat, cottage cheese, tofu, nuts, chickpeas, and beans.
However, there may be an underlying cause for their hair loss and rather than this being masked by using an off-the-shelf product, they should be encouraged to seek the advice of a specialist such as a Trichologist.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Guardian
2 hours ago
- The Guardian
Remember When by Fiona Phillips review – an unsparing insight into early-onset Alzheimer's
In 2019, the TV presenter and journalist Fiona Phillips booked a last-minute trip to Vietnam with a friend. Nothing unusual there, you might think. But not only did Phillips not invite her husband or children, she didn't consult them, instead simply informing them that she was leaving the following week. It was an impulsive decision that she hoped would lift her out of a depressive episode that was manifesting in brain fog and anxiety. But for her husband, TV editor Martin Frizell, it was another instance of Phillips behaving oddly, a sign that things 'were not all they should be'. Remember When chronicles, with illuminating candour, the changes that culminated in Phillips's diagnosis of early-onset Alzheimer's in 2022, at the age of 61. Billed as a memoir by Phillips herself, owing to her decline during the three-year writing process, it's really a co-production between her, her ghostwriter Alison Phillips (no relation) and Frizell, who provides fitful interjections. As such, it offers a rare account of the impact of Alzheimer's not just from the person who has it, but from their primary carer too. Frizell initially attributed his wife's symptoms to the menopause, which can also present as low mood and memory loss. Both wondered if she had long Covid, having been infected with the virus during the first lockdown. It's a reflection of the insidiousness of Alzheimer's that neither of them managed to join the dots until comparatively late, even though Phillips's mother and father had developed the disease in their 50s and 60s respectively. She had even made documentaries about her parents' decline, and was an ambassador for Alzheimer's charities. Yet, as this book makes clear, the memory loss that is intrinsic to Alzheimer's makes it unfathomable to the sufferer. How can you pinpoint what is going wrong with your brain when the main symptom is confusion? Among the early signs, Phillips reflects, was a feeling of flatness. She recalls going for a walk on Clapham Common in early summer 2018 and looking at other Londoners enjoying the weather. 'It was like looking through a double-glazed window on to another world of which I had no part. It was a strange sense of disconnection. Of seeing others laughing, enjoying the moment, while increasingly I felt, well, nothing. Just flat.' At this point in the book, Phillips presses pause on the story of her illness to trace her early years growing up in Canterbury and, later, Southampton. Along with her childhood, we get a whistle-stop tour of her career in journalism: after starting out in local radio, she began working for Sky News and later got a job reporting for GMTV from Los Angeles. On her return to the UK in 1997, she succeeded Anthea Turner as co-host alongside Eamonn Holmes, interviewing prime ministers and Hollywood stars. The intention of this determinedly breezy segment is clear: to let us know the fearless and successful person Phillips had been before Alzheimer's did its worst. Yet it is also revealing about the impossible juggle of fronting Britain's leading TV breakfast show and raising a young family, while caring for her parents through their own diagnoses. Her devastation at watching them disappear before her eyes is mirrored in Frizell as he observes his wife's incremental withdrawal from the world. This sadness erupts into anger when he states: 'I wish Fiona had contracted cancer … It's a shocking thing to say, but at least then she might have had a chance at a cure, and certainly would have had a treatment pathway, and an array of support and care packages.' As it is, following diagnosis, the Alzheimer's sufferer and their family are largely 'left to their own devices. There is nothing more that can be done and you are left to cope alone.' By the end of Remember When, Frizell's is the dominant voice, since Phillips no longer has the capacity to articulate her experience. Early in the book she says she doesn't want to become an object of pity, or for her story to be viewed as a tragedy. But there can be no happy ending here, no endnote of hope. Capturing the loneliness and sense of loss that occurs when a loved one is alive but no longer fully present, Frizell simply says: 'I miss her. I miss my wife.' Remember When by Fiona Phillips is published by Macmillan (£22). To support the Guardian, order your copy at Delivery charges may apply.


Daily Mail
3 hours ago
- Daily Mail
I was cured of one of the deadliest forms of cancer after trialling a new drug... my brain cancer is gone
A father who suffered with the world's deadliest form of brain cancer has been cleared after he underwent an experimental treatment. Ben Trotman, 43, who was diagnosed with glioblastoma in October 2022, is now showing no signs of the disease after being administered an immunotherapy drug in a world first two years ago. Most patients with the aggressive form of brain cancer typically die within 12-to-18 months. Consultant medical oncologist, Dr Paul Mulholland, who is leading the new trial and treated Mr Trotman, said: 'It is very unusual to have a clear scan with glioblastoma, especially when he didn't have the follow-up surgery that had been planned to remove all of the tumour that was initially visible on scans. 'We hope that the immunotherapy and follow-up treatment Ben has had will hold his tumour at bay – and it has so far, which we are delighted to see.' Mr Trotman married his wife Emily two months after the immunotherapy treatment in 2023, and in April, his daughter Mabel was born. The father-of-one said: 'Getting this diagnosis was the most traumatic experience. We were grappling with the fact that Ben had gone from being apparently perfectly healthy to having months to live. 'Had we not met Dr Mulholland, that would have been it for us. We felt we had a lucky break in an otherwise devastating situation.' Ben Trotman, 43, who was diagnosed with glioblastoma in October 2022, is now showing no signs of the disease after being administered an immunotherapy drug in a world first two years ago Mr Trotman went on to have the current standard treatment of radiotherapy and chemotherapy. He also undergoes quarterly cans, which continue to return clear. 'We obviously don't know what the future holds but having had the immunotherapy treatment and getting these encouraging scan results has given Emily and I a bit of hope,' he said. 'We are focused on rebuilding the life we thought we had lost and enjoying being parents'. The trial, from University College London Hospital's National Hospital for Neurology and Neurosurgery, follows a previous one on the same drug which closed because of lack of recruitment. But Dame Siobhain McDonagh MP lead a fundraising campaign to raise more than £1million to cover the costs of the new trials after her sister, Baroness McDonagh, died from glioblastoma in 2023. Dame Siobhain said: 'My beloved sister Margaret was appalled to discover that there had been no advances in brain cancer treatment for decades when she was diagnosed with glioblastoma. 'Changing this was Margaret's final campaign and one that I have continued in her memory. 'I am so grateful to the many people who knew and respected Margaret who have come together and helped to raise funds and campaign for this new trial that we are calling Margaret's Trial.' Dr Paul Mulholland said: 'When I met Margaret she said to me 'what can I do to support you to cure this disease?'. 'I am incredibly grateful to her and to Siobhain whose campaigning and fundraising in her sister's memory has led to this new clinical trial opening for patients with this most aggressive form of brain cancer that has such a poor prognosis, with most patients surviving just nine months after diagnosis. 'The crucial element of this trial is that patients will have their immune system boosted by the drug before they have any other treatment, when they are fit and well enough to tolerate the immunotherapy. 'We're taking everything we have learned from previous trials into this new study and we are already planning follow-on trials. 'My aim is to find a cure for glioblastoma.' The National Brain Appeal is currently funding two posts in support of Dr Mulholland's research. Treatment will take place at the NIHR UCLH's Clinical Research Facility and at the National Hospital for Neurology and Neurosurgery.


Daily Mail
3 hours ago
- Daily Mail
Diet that sheds weight fast by eating MORE: This easy plan was made to help cancer patients - then doctors realised its amazing benefits. JANE ALEXANDER tried it and couldn't believe how much she lost...
At the age of 65, I have reached crunch point. I'm sick to the back teeth of weird diets and I'm seriously fed up with feeling hungry. I'm also really hacked off at still being fat. It's not just how I look – my GP has told me I really need to lose my stores of visceral fat (the pernicious fat around the organs in the abdomen that is so bad for our health).